Personalized medicine: Lung Cancer leads the way

被引:12
|
作者
Parikh, P. [1 ]
Puri, T. [1 ]
机构
[1] Lung Canc Consortium Asia, Bombay, Maharashtra, India
关键词
GEFITINIB; IRESSA;
D O I
10.4103/0019-509X.117005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:77 / 79
页数:3
相关论文
共 50 条
  • [1] Personalized medicine for lung cancer
    Fong, Kwun M.
    Yang, Ian A.
    Bowman, Rayleen V.
    LUNG CANCER MANAGEMENT, 2012, 1 (02) : 83 - 86
  • [2] Advancing Personalized Cancer Medicine in Lung Cancer
    MacConaill, Laura E.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (10) : 1210 - 1216
  • [3] Lung Cancer - Genomics and Personalized Medicine
    Mahapatra, Anirban
    ACS CHEMICAL BIOLOGY, 2010, 5 (06) : 529 - 531
  • [4] Pathology and personalized medicine in lung cancer
    Kerr, Keith M.
    Loo, Peh Sun
    Nicolson, Marianne C.
    LUNG CANCER MANAGEMENT, 2013, 2 (01) : 35 - 46
  • [5] Molecular Therapy: Lung Cancer Leads the Way
    Hochster, Howard S.
    ONCOLOGY-NEW YORK, 2020, 34 (12): : 521 - 521
  • [6] Recent advances in personalized lung cancer medicine
    Okimoto, Ross A.
    Bivona, Trever G.
    PERSONALIZED MEDICINE, 2014, 11 (03) : 309 - 321
  • [7] Germline mutations in lung cancer and personalized medicine
    Francesco Cetta
    Alessandra Renieri
    Elisa Frullanti
    Familial Cancer, 2018, 17 : 429 - 430
  • [8] Interventional Radiology on Personalized Medicine for Lung Cancer
    Kim, T. J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1614 - S1614
  • [9] Chemotherapy for Lung Cancer in the Era of Personalized Medicine
    Lee, Seung Hyeun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2019, 82 (03) : 179 - 189
  • [10] A Personalized Medicine Approach to Lung Cancer and Melanoma
    Vnencak-Jones, C.
    Su, Z.
    Fohn, L.
    Coffin, C.
    Gonzalez, A.
    Itani, D.
    Shi, C.
    Sosman, J.
    Pao, W.
    LABORATORY INVESTIGATION, 2011, 91 : 447A - 447A